Cargando…
Association between exenatide use and incidence of Alzheimer's disease
INTRODUCTION: Recent developments suggest that insulin‐sensitizing agents used to treat type II diabetes (T2DM) may also prove useful in reducing the risk of Alzheimer's disease (AD). The objective of this study is to analyze the association between exenatide use among Medicare beneficiaries wi...
Autores principales: | Zhou, Bo, Zissimopoulos, Julie, Nadeem, Hasan, Crane, Matthew A., Goldman, Dana, Romley, John A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882542/ https://www.ncbi.nlm.nih.gov/pubmed/33614900 http://dx.doi.org/10.1002/trc2.12139 |
Ejemplares similares
-
Association between use of ß2-adrenergic receptor agonists and incidence of Parkinson’s disease: Retrospective cohort analysis
por: Nadeem, Hasan, et al.
Publicado: (2022) -
The association of multiple anti-hypertensive medication classes with Alzheimer’s disease incidence across sex, race, and ethnicity
por: Barthold, Douglas, et al.
Publicado: (2018) -
Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials
por: Vetter, Marion L., et al.
Publicado: (2019) -
Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis
por: Romley, John A, et al.
Publicado: (2015) -
Reduced racial disparity in receipt of optimal locoregional treatment for women with early-stage breast cancer
por: Nadeem, Hasan, et al.
Publicado: (2023)